Contact this trialFirst, we need to learn more about you.
PARP Inhibitor
Trabectedin + Olaparib for Sarcoma
Recruiting1 awardPhase 2
Ann Arbor, Michigan
This trial is testing how well two drugs work to treat patients with sarcoma that has spread or can't be removed with surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.